Evidence map›Paper›PMID 39946414›Full record

ArticleJMIR formative research2025

Acceptance of Unsupervised App-Based Cognitive Assessment in Outpatient Care: An Implementation Study.

Iris Blotenberg, Melanie Boekholt, Nils Lieberknecht, Paula Säring, Jochen René Thyrian

Abstract read
In one paragraph

Article in JMIR formative research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Iris BlotenbergGerman Center for Neurodegenerative Diseases (DZNE), Interventional Health Care Research, Ellernholzstr. 1-2, Greifswald, 17489, Germany, 49 3834-86-19534.ORCID 0000-0002-2273-5564
Melanie BoekholtGerman Center for Neurodegenerative Diseases (DZNE), Interventional Health Care Research, Ellernholzstr. 1-2, Greifswald, 17489, Germany, 49 3834-86-19534.ORCID 0000-0002-0576-0012
Nils Lieberknechtneotiv GmbH, Magdeburg, Germany.ORCID 0009-0003-6714-9061
Paula Säringneotiv GmbH, Magdeburg, Germany.ORCID 0009-0006-6388-5055
Jochen René ThyrianGerman Center for Neurodegenerative Diseases (DZNE), Interventional Health Care Research, Ellernholzstr. 1-2, Greifswald, 17489, Germany, 49 3834-86-19534.ORCID 0000-0001-6889-693X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The use of unsupervised digital cognitive assessments provides considerable opportunities for early and comprehensive testing for Alzheimer disease, minimizing the demand on time and personnel resources in medical practices. However, the acceptance within health care has yet to be assessed. Objective: In this implementation study, the acceptance of an app-based, repeated cognitive assessment for early symptoms of Alzheimer disease in the outpatient care setting from both physicians' and patients' perspectives was examined. Methods: In total, 15 primary care practices participated, where patients with self- or relative-reported memory problems could be prescribed an app (neotivCare app [neotiv GmbH]) for comprehensive cognitive testing. Patients used the app to test their episodic memory function weekly for 12 weeks at home. After the testing period and the final consultation, physicians and patients received questionnaires to assess the app's acceptance. Results: We received completed questionnaires from physicians for 45 patients. In addition, we received 45 completed questionnaires from the patients themselves. The physicians reported that, for most patients, the app supported their decision-making in the diagnostic process (26/45, 58%). In addition, most physicians found the app's information dependable (34/45, 76%) and felt more certain in their decisions (38/45, 84%). From the patients' perspective, a majority felt thoroughly tested (34/45, 76%), and only a few considered the time commitment for the cognitive tests to be too burdensome (7/45, 16%). Furthermore, despite the weekly cognitive testing and the lengthy 12-week testing period, a majority of patients participated in all tests (39/54, 72%). Conclusions: Our results indicate a high level of acceptance by physicians and patients, suggesting significant potential for the implementation of unsupervised digital cognitive assessments into routine health care. In the future, acceptance should be assessed in large-scale studies, with a particular focus on the impact on health care delivery and patient outcomes.

Indexed as

Alzheimer DiseaseAmbulatory CareMobile ApplicationsPatient Acceptance of Health CareAgedAged, 80 and overFemaleHumansMaleMiddle AgedPrimary Health CareSurveys and QuestionnairesAlzheimer diseasecognitioncomputerized assessmentdementiadigital assessmentdigital cognitive biomarkersdigital platformhome-based assessmentmild cognitive impairmentmobile phone

Identifiers

PMID39946414
PMCPMC11841747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.